Navigation Links
Chinese Scientists Zhen-Yi Wang and Zhu Chen Awarded 7th Annual Szent-Gyorgyi Prize for Progress in Cancer Research
Date:1/24/2012

BETHESDA, Md., Jan. 24, 2012 /PRNewswire/ -- The National Foundation for Cancer Research announced today that Dr. Zhen-Yi Wang and Dr. Zhu Chen have been awarded the 7th annual Szent-Gyorgyi Prize for Progress in Cancer Research for their innovative research that led to the successful development of a new therapeutic approach to acute promyelocytic leukemia (APL). 

By combining traditional Chinese medicine with Western medicine, Drs. Wang and Chen have provided dramatic improvement in the five-year disease-free survival rate of APL patients - from approximately 25 percent to 95 percent - making this therapy a standard of care for APL treatment throughout the world, and turning one of the most fatal diseases into a highly curable one.

"I am so glad to see that the efforts we have devoted to research on leukemia these last several decades have led to solid clinical benefits to APL patients around the world," said Dr. Wang. "This award will inspire us as we continue our efforts to find more effective therapies to treat cancers." 

"This is a great honor for Dr. Wang and me; it is quite humbling to know that our respected colleagues from many  scientific disciplines have selected us for this prestigious award," said Dr. Chen, who also serves as China's Minister of Health. "Scientists across the globe are working every day to cure cancer. I hope our work may continue to inspire others."

A clinical researcher at the Ruijin Hospital in Shanghai in the early 1980s, Dr. Zhen-Yi Wang performed the first successful therapy on APL patients using all-trans retinoic acid (ATRA), which significantly increased the survival rate of patients with APL. Dr. Zhu Chen, a former student of Wang, made major contributions to the identification of the molecular mechanisms of both ATRA and arsenic trioxide in APL. He also demonstrated in clinical trials that arsenic trioxide, a compound used as a traditional Chinese medicine for over 2,
'/>"/>

SOURCE The National Foundation for Cancer Research
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
2. Cracking the Code: Exclusive Conference to Reveal Secrets of Chinese Pharmaceutical Industry
3. Miami Beach Real Estate Attorney Announces Services to Assist Chinese and other International Real Estate Investors Purchase Discount Florida Homes
4. DuPont and Chinese Academy of Agricultural Sciences Collaborate to Advance Crop Insect Control, Increase Yield
5. SAFC Biosciences(R) Expands Media Capability for Chinese Hamster Ovary (CHO) Cell Lines
6. Sinobiopharma Applies For Two Chinese Patents For Cisatracurium Besylate
7. Neogen Partners With Chinese Government
8. MIT is pleased to announce that it has received a US$ 500,000 private placement from its Chinese partners
9. WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise
10. NeoStem, Inc. Appoints Leading Chinese Medical Official to Its Advisory Board
11. SAFC Biosciences(R) Defines Hydrolysate Components That Enhance Chinese Hamster Ovary (CHO) Cell Line Protein Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 25 novembre 2014 /PRNewswrie/ -- Theravalues Corporation annuncia con ... europeo in occasione di Hi Europe 2014 (dal 2 ... Si tratta della curcumina con la maggiore biodisponibilità ... cristalli) e ingredienti approvati dalle norme europee. ... della pianta curcumina ( Curcuma longa ) che è ...
(Date:11/24/2014)... , Nov. 24, 2014  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA), which ... 2014 to seven, with eighteen submissions now pending at ... President and CEO of the Company, commented, "Our team ...
(Date:11/24/2014)... 2014  Last week, Representatives Gus Bilirakis ... took a bold bipartisan step on behalf of ... Act. Original co-sponsors of the legislation include Representatives ... incentivize drug makers and innovators to "repurpose" major ... cancers, which opens the door to the development ...
(Date:11/24/2014)...   First published ... Elsevier , a world-leading provider of scientific, technical ... the launch of the latest title in the Current ... Food Science . Current ... new platform to keep up-to-date with the expanding volume of ...
Breaking Biology Technology:La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 3IGI Laboratories, Inc. Announces ANDA Submission 2OPEN Act Introduced to Repurpose Drugs for Rare Diseases 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 3
... University of California, Berkeley, have developed a pressure-sensitive electronic ... new meaning to the term "thin-skinned." "The ... the human skin, which means incorporating the ability to ... of electrical engineering and computer sciences and head of ...
... Spotlights Innovations During ESTRO29 -- VEENENDAAL, The Netherlands, September 10, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... lure of greater profits elsewhere in the world may ... and distribution of affordable drugs, vaccines and diagnostics for ... millions of poor people, experts warn. And they ... support for continuing the success of firms finding homegrown ...
Cached Biology Technology:Engineers make artificial skin out of nanowires 2Engineers make artificial skin out of nanowires 3Nucletron Spotlights Innovations During ESTRO29 2Nucletron Spotlights Innovations During ESTRO29 3Nucletron Spotlights Innovations During ESTRO29 4Nucletron Spotlights Innovations During ESTRO29 5Nucletron Spotlights Innovations During ESTRO29 6Nucletron Spotlights Innovations During ESTRO29 7Global health vs. global wealth: Looming choice for health firms in developing countries 2Global health vs. global wealth: Looming choice for health firms in developing countries 3Global health vs. global wealth: Looming choice for health firms in developing countries 4
(Date:11/4/2014)... – University of Utah engineers developed the first room-temperature ... produce electricity without needing to ignite the fuel. These ... electronics, off-grid power and sensors. , A study of ... Chemical Society journal ACS Catalysis . , Fuel ... between a fuel and an oxygen-rich source such as ...
(Date:11/4/2014)... study examining only marketing directed at children on ... has found that the majority of black, middle-income ... marketing tactics. , Authored by Arizona State University ... is the first to examine the use of ... fast food restaurants and its relationship to demographics. ...
(Date:11/3/2014)... , Nov. 3, 2014 Research and Markets ... "Cell Therapy - Technologies, Markets and Companies" to their ... therapy technologies and methods, which have already started to play ... cell transplantation is replacing the old fashioned bone marrow transplants. ... therapy is bound to become a part of medical practice. ...
Breaking Biology News(10 mins):Jet-fueled electricity at room temperature 2Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3
... Scientists at Joslin Diabetes Center have identified biological mechanisms ... against kidney disease, and also mechanisms that inhibit its ... online by Diabetes, may lead to the development of ... to prevent the harmful effects of hyperglycemia on renal ...
... melanoma is a malignant form of skin cancer and ... there is. Treatment is particularly difficult, because melanomas are ... Chris Marine, (VIB/KU Leuven) have found a new line ... cancers, namely by combating the interaction between the protein ...
... observes a colorful jellyfish pulsating through the ocean, Greek ... animal once was known as the medusa, after the ... gaze turned people into stone, and now, thanks to ... researchers at the California Institute of Technology (Caltech) and ...
Cached Biology News:Joslin researchers gain new understanding of diabetes and kidney disease 2Joslin researchers gain new understanding of diabetes and kidney disease 3New line of approach for combination therapy against melanoma 2Medusa reimagined: Caltech-led team reverse engineers a jellyfish with the ability to swim 2Medusa reimagined: Caltech-led team reverse engineers a jellyfish with the ability to swim 3Medusa reimagined: Caltech-led team reverse engineers a jellyfish with the ability to swim 4
Request Info...
Purified anti-eIF-4E...
Peptide-affinity Purified Polyclonal Antibody to SMAD7 Peptide with sequence SSCPCWLEVIFNSR, from C Terminus of the protein sequence according to NP_005895....
Purified anti-PXR...
Biology Products: